Biologic Agents in the Management of Hodgkin Lymphoma

Journal of the National Comprehensive Cancer Network : JNCCN - United States
doi 10.6004/jnccn.2015.0076
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Harborside Press, LLC

Related search

Novel Therapeutic Agents for Relapsed Classical Hodgkin Lymphoma

British Journal of Haematology
Hematology
2018English

Modern Principles in the Management of Nodular Lymphocyte-Predominant Hodgkin Lymphoma

British Journal of Haematology
Hematology
2018English

Pcn78 - Evaluating the Economic Consequences of Novel Agents for Treating Hodgkin Lymphoma in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Hodgkin Lymphoma in Pregnancy

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2013English

Classic Hodgkin Lymphoma

Mayo Clinic Proceedings
Medicine
2018English

Treatment of Relapsed and Refractory Hodgkin Lymphoma – Recommendations of the Czech Hodgkin Lymphoma Study Group

Klinicka Onkologie
Oncology
2016English

Classic Hodgkin Lymphoma

2020English

Non-Hodgkin Lymphoma

2020English

The Translational Science of Hodgkin Lymphoma

British Journal of Haematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy